For HCC, considerable studies have confirmed that the malignant progression of the tumor cells is related with dysfunctions of several signaling pathways, such as PI3K/AKT, Wnt/β-catenin, and P53 pathways [20–22]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.